Twelve Points Wealth Management LLC Sells 8,616 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Twelve Points Wealth Management LLC decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,638 shares of the pharmacy operator’s stock after selling 8,616 shares during the quarter. Twelve Points Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $249,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. State Street Corp raised its stake in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after purchasing an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC boosted its position in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after buying an additional 934,754 shares in the last quarter. Finally, FMR LLC grew its stake in Walgreens Boots Alliance by 2.5% during the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after buying an additional 80,525 shares during the last quarter. 58.59% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on WBA shares. Morgan Stanley cut their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Jefferies Financial Group lowered their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Truist Financial increased their price objective on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Thursday, January 16th. Finally, Barclays boosted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $13.27.

Walgreens Boots Alliance Trading Up 3.3 %

NASDAQ WBA opened at $11.25 on Thursday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $23.76. The stock has a 50-day simple moving average of $9.96 and a 200 day simple moving average of $9.86. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period last year, the company posted $0.66 EPS. On average, analysts expect that Walgreens Boots Alliance, Inc. will post 1.59 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.